{{Rsnum
|rsid=229527
|Gene=C1QTNF6
|Chromosome=22
|position=37185445
|Orientation=minus
|GMAF=0.4619
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=C1QTNF6
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 34.5 | 50.4 | 15.0
| HCB | 3.7 | 41.9 | 54.4
| JPT | 21.2 | 38.1 | 40.7
| YRI | 44.2 | 37.4 | 18.4
| ASW | 33.3 | 54.4 | 12.3
| CHB | 3.7 | 41.9 | 54.4
| CHD | 11.9 | 45.0 | 43.1
| GIH | 44.6 | 39.6 | 15.8
| LWK | 43.6 | 47.3 | 9.1
| MEX | 32.8 | 55.2 | 12.1
| MKK | 34.0 | 50.6 | 15.4
| TSI | 31.4 | 52.9 | 15.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20410501
|Trait=Vitiligo
|Title=Variant of TYR and Autoimmunity Susceptibility Loci in Generalized Vitiligo
|RiskAllele=T
|Pval=2E-16
|OR=1.38
|ORtxt=[1.28-1.50]
|OA=1
}}

{{PMID|19474294|OA=1
}} Potential etiologic and functional implications of genome-wide association loci for human diseases and traits.

{{GET Evidence
|gene=C1QTNF6
|aa_change=Gly21Val
|aa_change_short=G21V
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs229527
|overall_frequency_n=4281
|overall_frequency_d=10758
|overall_frequency=0.397936
|n_genomes=37
|n_genomes_annotated=0
|n_haplomes=46
|n_articles=0
|n_articles_annotated=0
|nblosum100=8
|autoscore=0
|webscore=N
}}

{{PMID Auto GWAS
  |PMID=23612905
  |Trait=Graves' disease
  |Title=Robust evidence for five new Graves' disease risk loci from a staged genome-wide association analysis.
  |RiskAllele=
  |Pval=5E-20
  |OR=1.23
  |ORtxt=[1.19-1.3]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}